FDA approves weight-loss drug Zepbound to treat sleep apnea - The Washington Post


12/21/2024

FDA approves weight-loss drug Zepbound to treat sleep apnea  The Washington PostF.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea  The New York TimesFDA Approves First Medication for Obstructive Sleep Apnea  FDA.govFDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity  Investors | Eli Lilly and CompanyFDA approves Eli Lilly’s obesity medication for obstructive sleep apnea  ABC News...

Original

Tags: drug | fda | loss | news | post | sleep | treat | washington | york



Let us know what you think!

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Leave a Comment

Scroll back to top